Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.

“Hepatocellular carcinoma (HCC) is the leading cause of cancer-associated mortality worldwide; however, only limited therapeutic treatments are currently available.

The present study aimed to investigate the effects of cannabinoids as novel therapeutic targets in HCC…

These results suggested that cannabinoid receptor agonists, including WIN, may be considered as novel therapeutics for the treatment of HCC.”

http://www.ncbi.nlm.nih.gov/pubmed/26500101

http://www.thctotalhealthcare.com/category/hepatocellular-carcinoma-hcc/

Facebook Twitter Pinterest Stumbleupon Tumblr Posterous

Leave a Reply

Your email address will not be published. Required fields are marked *